Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-28
Original SEC Filing: Click here
Webplus: SVA/20090928/6-K/2_EX-99.1/000.htm SEC Original: sinovacexh99_1.htm
Sinovac to Present at 2009 UBS Global Life Sciences Conference BEIJING, Sept. 16 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that Mr. Weidong Yin, Chairman, President & CEO, will present at the 2009 UBS Global Life Sciences Conference in New York City. The presentation is scheduled for Tuesday, September 22,
Webplus: SVA/20090928/6-K/1/000.htm SEC Original: sinovac6k091609.htm
FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4
Company Information:
Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-28CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085
-
- Forum
- Topics
- Last Post
Leave A Comment
You must be logged in to post a comment.